AMPH
Price
$31.28
Change
-$0.02 (-0.06%)
Updated
Feb 21 closing price
Capitalization
2.11B
17 days until earnings call
AMRX
Price
$7.83
Change
-$0.04 (-0.51%)
Updated
Feb 21 closing price
Capitalization
1.87B
5 days until earnings call
Ad is loading...

AMPH vs AMRX

Header iconAMPH vs AMRX Comparison
Open Charts AMPH vs AMRXBanner chart's image
Amphastar Pharmaceuticals
Price$31.28
Change-$0.02 (-0.06%)
Volume$523.51K
Capitalization2.11B
Amneal Pharmaceuticals
Price$7.83
Change-$0.04 (-0.51%)
Volume$1.31M
Capitalization1.87B
AMPH vs AMRX Comparison Chart
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. AMRX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Hold and AMRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (AMPH: $31.28 vs. AMRX: $7.83)
Brand notoriety: AMPH and AMRX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 90% vs. AMRX: 120%
Market capitalization -- AMPH: $2.11B vs. AMRX: $1.87B
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. AMRX’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileAMRX’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • AMRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both AMPH and AMRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while AMRX’s TA Score has 3 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 3 bearish.
  • AMRX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than AMRX.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а +0.84% price change this week, while AMRX (@Pharmaceuticals: Other) price change was +1.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.14%. For the same industry, the average monthly price growth was +77.04%, and the average quarterly price growth was +50.35%.

Reported Earning Dates

AMPH is expected to report earnings on May 08, 2025.

AMRX is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($2.11B) has a higher market cap than AMRX($1.87B). AMRX has higher P/E ratio than AMPH: AMRX (90.00) vs AMPH (16.69). AMRX YTD gains are higher at: -1.136 vs. AMPH (-15.755). AMRX has higher annual earnings (EBITDA): 400M vs. AMPH (240M). AMPH has more cash in the bank: 257M vs. AMRX (91.5M). AMPH has less debt than AMRX: AMPH (624M) vs AMRX (2.75B). AMRX has higher revenues than AMPH: AMRX (2.39B) vs AMPH (644M).
AMPHAMRXAMPH / AMRX
Capitalization2.11B1.87B113%
EBITDA240M400M60%
Gain YTD-15.755-1.1361,386%
P/E Ratio16.6990.0019%
Revenue644M2.39B27%
Total Cash257M91.5M281%
Total Debt624M2.75B23%
FUNDAMENTALS RATINGS
AMPH vs AMRX: Fundamental Ratings
AMPH
AMRX
OUTLOOK RATING
1..100
668
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
94
Overvalued
PROFIT vs RISK RATING
1..100
6555
SMR RATING
1..100
4098
PRICE GROWTH RATING
1..100
8957
P/E GROWTH RATING
1..100
9427
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (64) in the Pharmaceuticals Other industry is in the same range as AMRX (94) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (55) in the Pharmaceuticals Major industry is in the same range as AMPH (65) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's SMR Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (98) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Price Growth Rating (57) in the Pharmaceuticals Major industry is in the same range as AMPH (89) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to AMPH’s over the last 12 months.

AMRX's P/E Growth Rating (27) in the Pharmaceuticals Major industry is significantly better than the same rating for AMPH (94) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew significantly faster than AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHAMRX
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
68%
Bearish Trend 16 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VDSCX18.32-0.32
-1.72%
Victory Diversified Stock C
CNGFX62.30-1.34
-2.11%
American Funds New Economy 529F
OCMAX16.67-0.42
-2.46%
OCM Gold Atlas
VYRIX11.78-0.42
-3.44%
VY® T. Rowe Price Divers Mid Cap Gr R6
PRDMX46.83-1.71
-3.52%
T. Rowe Price Diversified Mid Cap Gr

AMPH and

Correlation & Price change

A.I.dvisor tells us that AMPH and AMRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMPH and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-0.06%
AMRX - AMPH
32%
Poorly correlated
-0.51%
EOLS - AMPH
28%
Poorly correlated
-4.31%
VTRS - AMPH
28%
Poorly correlated
+1.72%
HROW - AMPH
28%
Poorly correlated
-3.92%
SUPN - AMPH
26%
Poorly correlated
-4.45%
More

AMRX and

Correlation & Price change

A.I.dvisor tells us that AMRX and HROW have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMRX and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-0.51%
HROW - AMRX
32%
Poorly correlated
-3.92%
CRON - AMRX
32%
Poorly correlated
+1.55%
ORGO - AMRX
32%
Poorly correlated
-5.03%
VTRS - AMRX
30%
Poorly correlated
+1.72%
VRNOF - AMRX
30%
Poorly correlated
N/A
More